Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-Arm Prospective Study to Evaluate Safety and Efficacy of GLE/PIB 8-Week Treatment in Adults and Adolescents With Acute Hepatitis C Virus (HCV) Infection

NCT04903626 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04903626
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04903626 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-Arm Prospective Study to Evaluate Safety and Efficacy of GLE/PIB 8-Week Treatment in Adults and Adolescents With Acute Hepatitis C Virus (HCV) Infection
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
August 24, 2021
Completion date
September 17, 2024
Enrollment
286 (actual)
Sites
70

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c virus (hcv)